Picture of Biohit Oyj logo

BIOBV — Biohit Oyj News Story

0.000.00%
fi flag iconLast trade - 00:00
HealthcareAdventurousMicro CapContrarian

Brief: Biohit GastroPanel tests to be used in gastric cancer screening study in China

July 16 (Reuters) - Biohit Oyj  BIOBV.HE : 
    * Gastric cancer screening study to start in China with at least 20,000 
people to be screened by Biohit Oyj's GastroPanel test, with over 50 hospitals 
participating 
    * Says screenings are set to begin in 2015 and end in December 2016 
 
     
Source text for Eikon:  ID:nHSU5W3m  
     
Further company coverage:  BIOBV.HE  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))

Recent news on Biohit Oyj

See all news